GLP-1 receptor agonist combined with biguanide

This page covers all GLP-1 receptor agonist combined with biguanide drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting GLP-1R; AMPK pathway.

Targets

GLP-1R; AMPK pathway

Marketed (1)

• semaglutide combined with metformin · The First Affiliated Hospital of Xiamen University · Diabetes
  Semaglutide activates GLP-1 receptors to enhance insulin secretion and reduce appetite, while metformin decreases hepatic glucose production and improves insulin sensitivity.

Patent intelligence

• glp 1 receptor agonist combined with biguanide patent landscape — aggregated cliff calendar, attackable patents, originator estates